Concern Sparks over Panic Procurement of Hydroxychloroquine

-

The magnitude of demand destruction prevailing due to Coronavirus is beyond all threshold values anticipated by any economy. This global pandemic has caused devastating slowdown in diverse industrial sectors with no ray of hope for recovery in the coming months. The struggle to survive the outbreak is becoming intense with every passing day on increasing number of cases and death tolls. With affected countries eyeing on supplies of drugs and equipments to combat the virus, Hydroxychloroquine (HCQ) drug has become a major potential necessity as it is reported to be serving well for the treatment of the disease. Hydroxychloroquine is a drug typically used for treating malaria and other immunity syndromes like lupus and rheumatoid arthritis.

Visit more info: https://www.chemanalyst.com/NewsAndDeals/NewsDetails/pharma-stocks-skyrocket-over-rising-demand-for-hydroxychloroquine-1245

The demand for HCQ has been intensified since the day Trump, president of U.S, released a statement mentioning it as “Gift from God”, a miraculous cure for Covid-19. U.S is reported to be the worst hit country by novel virus with highest number of cases and death tolls. As a preventive measure, the country is looking forward to stockpile supplies of Hydroxychloroquine from Indian pharmaceuticals, so that the treatment is not hindered. Although, there hasn’t been any official probe or declaration form leading health organisations like FDA and WHO confirming over the effectiveness of the drug in treating patients tested positive with COVID-19. Over the news of a miraculous drug, sudden excitement for procurement of Hydroxychloroquine has been noticed within the affected countries. India, regarded as the world pharmacy of drugs, with exceptional capacity to make high quality and affordable drugs has come under tremendous pressure to cater to the unprecedented demand for HCQ considering the ‘humanitarian aspect’.

IPCA Pharmaceuticals, Mangalam Drugs and Zydus Cadilla, are leading manufacturers of raw material for HCQ in India whereas Wallace Pharmaceuticals and Cipla Pharmaceuticals are engaged in the production of HCQ itself. Pharma companies are ramping up their production capacities and aiming to enhance it by 5-6 times over rising stress on surge in demand for the drug. These pharmaceutical companies have assured enough stock to satisfy the domestic demand under priority. On the other hand, decision to export drugs to other countries will be based on the severity of the crises.

India being among the leading pharmaceutical drug manufacturing countries, was asked to remove ban on exports of critical drugs to encourage an easy flow of trade to the affected countries. On its part, extending a wholesome effort to stand united to eradicate this disease, it has relaxed ban on export of selective drugs. Although it is monitoring the production and demand of HCQ and paracetamol in the domestic market to ensure ample supply.

According to analysts, astonishing change in trade decisions taken over night might save the country against retaliations from U.S but the dilemma is , whether it  will continue to be effective for its own benefit when the number of cases will witness an alarming surge. Government needs to be smart to maintain two-way relations with U.S by mentioning about country’s stress on Remdesivir, the most promising treatment till date for Covid-19. Moreover, pandemic crises have highlighted the irony in India’s trade regulations that partially favours rich nations even in tough times. Considering the healthcare scenario of the nation, India should also focus on availability of these drugs at an affordable price for diseases like Cancer and Tuberculosis. The shift in export regulation comes with several stressing loopholes but in contrast, this can be an exceptional opportunity for Pharma and Healthcare industries eyeing to widen their profit margins by expanding their export business.

Comments

Post a Comment

Popular posts from this blog

Unlocking the Power of Phosphoric Acid: From Production Methods to Practical Applications

-
Image
H3PO4, often referred to as Orthophosphoric acid or   Phosphoric acid , is a silent hero in our daily routines that might not be well known but plays a vital role. This acid, which is very useful, finds uses in fertilizers that feed our crops, carbonated beverages we love, and many more! It is the same question that follows: how is this acid being manufactured and what are the places where we find it? In this blog, we are going to take a glance at the really interesting world of phosphoric acid. We shall look at the two processes which are adopted for the production of it, i.e., wet and thermal processes. Following that, we will unravel the mystery behind its diverse uses, including its involvement in agriculture and the fact that it is surprisingly a component of our cosmetics and food! We’ll explore handful of its many applications such as: Food science:  It gives a fresh and strong kick to processed foods and drinks, while also working as a preservative. Plant power:  ...
Read more

Wheat Prices, Demand & Supply | ChemAnalyst

-
Image
The final quarter of 2023 presented challenges for the North American  Wheat prices , as a variety of factors influenced prices, leading to a mixed trend. Beginning in October 2023, there was a notable uptick in the cost of wheat, diverging from the consistent decline observed in previous months. This increase in prices was closely tied to Canada, a major wheat exporter, facing a significant reduction in its Durum wheat harvest. The repercussions of this reduction affected all wheat varieties, contributing to an overall price surge. Adverse weather conditions, particularly dry spells in crucial farming regions, were identified as the primary causes, resulting in decreased yields and depleting stocks for major exporters, reaching some of the lowest levels in recent times. Moving into November, there was an abundance of locally sourced goods on the supply side, accompanied by a slowdown in trade orders as downstream consumption notably declined, as reflected in the 3.0 percent decrea...
Read more

A Bird’s Eye View on the Outcome of US Elections on India’s Energy Sector

-
Image
As US heads towards Presidential Elections, the energy policy makers in India are keeping a close watch on the results which would decide its impact on the India-US ties. While Joe Biden promises strong push towards renewable energy sources, Trump’s victory may strengthen India’s oil, infra and defense sector. As soon as incumbent Donald Trump pulled US out of the Paris climate change agreement, which aims at mitigating the impact of greenhouse gas emissions on the global temperature rise, Biden launched a campaign promising the US to achieve the target of net zero emissions by 2050 and investing USD 1.7 trillion in the next ten years towards actualizing the same.  Get more info : https://www.chemanalyst.com/NewsAndDeals/NewsDetails/a-birds-eye-view-on-the-outcome-of-us-elections-on-indias-energy-sector-3399 Biden’s proposal sounds well when India has already shifted to fifth gear towards increasing its capacity of clean energy projects. Clean energy projects comprise nearly a fift...
Read more